PACeS
Anticoagulation | Atrial Fibrillation | Cardiac Surgery | Atrial Flutter | CABG | Heart SurgeryThis study is to compare two treatments for atrial fibrillation or atrial flutter (both referred to as AF) after cardiac surgery. AF is the most common irregular heartbeat after surgery and is associated with increased risk of stroke, heart failure and hospitalization. Patients who have this heartbeat are also at higher risk of developing blood clots. This study is to determine which of two standard hospital treatments is safer for patients after Coronary Artery Bypass Graft surgery. Antiplatelet or anticoagulants. Antiplatelet drugs (like aspirin) prevent clots from forming by stopping platelets (blood cell fragments) from clumping together where anticoagulants (like warfarin or apixaban) "thin" blood so it is less likely to clot.
null
Participation Requirements
-
Sex:
Any -
Eligible Ages:
18 and up
Participation Criteria
Inclusion Criteria:
Anybody over the age of 18 undergoing an isolated CABG surgery.
Exclusion Criteria:
- previous atrial fibrillation
- any other type of heart surgery
- chronic kidney disease
- liver cirrhosis or Child-Pugh class c
- pregnant or breastfeeding
- any underlying disease limiting life expectancy to less than one year
Study Location
University of Alberta
University of AlbertaEdmonton, Alberta
Canada
Contact Study Team
- Study Sponsored By
- University of Alberta
- Participants Required
- More Information
- Study ID:
Pro00098055